Fluorescent polymer nanoparticle-based drug delivery system for treatment of colorectal cancer by modulating RELL1
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Esophageal Cancer Research and Treatment · MicroRNA in disease regulation · Endoplasmic Reticulum Stress and Disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Thanikachalam K, Khan G (2019) Colorectal cancer and nutrition. Nutrients 11:16410.3390/nu11010164 ↗
2. Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA (2021) Genetic and biological hallmarks of colorectal cancer. Genes Dev 35:787–82010.1101/gad.348226.120 ↗
3. Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, Gad M, Al-Husseini M, Saad A (2021) Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets 22:998–100910.2174/18735592MTEx9NTk2y ↗
4. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR (2022) The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 7:262–27410.1016/S2468-1253(21)00426-X ↗
5. Mahmoud NN (2022) Colorectal cancer: preoperative evaluation and staging. Surg Oncol Clin N Am 31:127–14110.1016/j.soc.2021.12.001 ↗
6. Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, Bailey C, Lieu CH (2022) A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol 23:e116–e12810.1016/S1470-2045(21)00588-X ↗
7. Rabiee N (2023) Sustainable metal-organic frameworks (MOFs) for drug delivery systems. Mater Today Commun 35:10624410.1016/j.mtcomm.2023.106244 ↗
8. Vikal A, Maurya R, Patel P, Paliwal SR, Narang RK, Gupta GD, Kurmi BD (2024) Exploring metal-organic frameworks (MOFs) in drug delivery: a concise overview of synthesis approaches, versatile applications, and current challenges. Appl Mater Today 41:10244310.1016/j.apmt.2024.102443 ↗
9. Ding M, Liu W, Gref R (2022) Nanoscale MOFs: from synthesis to drug delivery and theranostics applications. Adv Drug Del Rev 190:11449610.1016/j.addr.2022.114496 ↗
10. Cai M, Qin L, You L, Yao Y, Wu H, Zhang Z, Zhang L, Yin X, Ni J (2020) Functionalization of MOF-5 with mono-substituents: effects on drug delivery behavior. RSC Adv 10:36862–3687210.1039/D0RA06106A ↗
11. Khan S, Falahati M, Cho WC, Vahdani Y, Siddique R, Sharifi M, Jaragh-Alhadad LA, Haghighat S, Zhang X, Hagen TLM, Bai Q (2023) Core–shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment. Adv Colloid Interface Sci 321:10300710.1016/j.cis.2023.103007 ↗
12. Cao Q, Zhang Y, Tang Y, Wu C, Wang J, Li D (2024) MOF-based magnetic microrobot swarms for pH-responsive targeted drug delivery. Sci China Chem 67:1216–122310.1007/s11426-023-1875-7 ↗
13. Lawson HD, Walton SP, Chan C (2021) Metal–organic frameworks for drug delivery: a design perspective. ACS Appl Mater Interfaces 13:7004–702010.1021/acsami.1c01089 ↗
14. Zhang Q, Li J, Zu W, Yang H, Wang Y (2021) One-pot synthesis of Eu-MOFs for bioimaging and drug delivery. Drug Dev Ind Pharm 47:1175–118210.1080/03639045.2021.1988100 ↗
15. Li X, Tan TTY, Lin Q, Lim CC, Goh R, Otake KJ, Kitagawa S, Loh XJ, Lim JYC (2023) MOF–thermogel composites for differentiated and sustained dual drug delivery. ACS Biomater Sci Eng 9:5724–573610.1021/acsbiomaterials.3c01103 ↗
16. Elmehrath S, Nguyen HL, Karam SM, Amin A, Greish YE (2023) BioMOF-based anti-cancer drug delivery systems. Nanomaterials 13:95310.3390/nano13050953 ↗
17. Gandara-Loe J, Souza BE, Missyul A, Giraldo G, Tan JC, Silvestre-Albero J (2020) MOF-based polymeric nanocomposite films as potential materials for drug delivery devices in ocular therapeutics. ACS Appl Mater Interfaces 12:30189–3019710.1021/acsami.0c07517 ↗
18. Cai W, Wang J, Chu C, Chen W, Wu C, Liu G (2019) Metal–organic framework-based stimuli-responsive systems for drug delivery. Adv Sci 6:180152610.1002/advs.201801526 ↗
19. Jeyaseelan C, Jain P, Soin D, Gupta D (2022) Metal organic frameworks: an effective application in drug delivery systems. Inorg Nano-Met Chem 52:1463–147510.1080/24701556.2021.1956966 ↗
20. Bendre A, Hegde V, Ajeya KV, Thagare Manjunatha S, Somasekhara D, Nadumane VK, Kant K, Jung HY, Hung WS, Kurkuri MD (2023) Microfluidic-assisted synthesis of metal—organic framework —alginate micro-particles for sustained drug delivery. Biosensors 13:73710.3390/bios13070737 ↗
21. Luo Q, Yang Y, Ho C, Li Z, Chiu W, Li A, Dai Y, Li W, Zhang X (2024) Dynamic hydrogel–metal–organic framework system promotes bone regeneration in periodontitis through controlled drug delivery. J Nanobiotechnol 22:28710.1186/s12951-024-02555-9 ↗
22. Karakeçili A, Topuz B, Ersoy FŞ, Şahin T, Günyakti A, Demirtaş TT (2022) UiO-66 metal-organic framework as a double actor in chitosan scaffolds: antibiotic carrier and osteogenesis promoter. Biomater Adv 136:21275710.1016/j.bioadv.2022.212757 ↗
23. Bina A, Raissi H, Zaboli A (2024) Exploring the potential use of natural polymers to enhance the performance of MXene/MOF-5 nanocarrier in loading and co-loading of doxorubicin and curcumin. Polym Bull 81:8383–840410.1007/s00289-023-05099-4 ↗
24. Rengasamy G, Mahalingam S, Udaiyar T, Kalirajan M (2024) Biocompatability chitosan /Aloe barbadensis miller loaded moxifloxacin composite film: a multifunctional bio-platform for the treatment of breast cancer. J Mol Struct 1315:13861810.1016/j.molstruc.2024.138618 ↗
25. Gao X, Hai X, Baigude H, Guan W, Liu Z (2016) Fabrication of functional hollow microspheres constructed from MOF shells: promising drug delivery systems with high loading capacity and targeted transport. Sci Rep 6:3770510.1038/srep37705 ↗
26. Taghikhani A, Babazadeh M, Davaran S, Ghasemi E (2024) Facile preparation of a pH-sensitive biocompatible nanocarrier based on magnetic layered double hydroxides/Cu MOFs-chitosan crosslinked к-carrageenan for controlled doxorubicin delivery to breast cancer cells. Colloids Surf B Biointerfaces 243:11412210.1016/j.colsurfb.2024.114122 ↗
27. Hidalgo T, Giménez-Marqués M, Bellido E, Avila J, Asensio MC, Salles F, Lozano MV, Guillevic M, Simón-Vázquez R, González-Fernández A, Serre C, Alonso MJ, Horcajada P (2017) Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers. Sci Rep 7:4309910.1038/srep43099 ↗
28. Akbari M, Ghasemzadeh MA, Fadaeian M (2020) Synthesis and application of ZIF-8 MOF incorporated in a TiO2@Chitosan nanocomposite as a strong nanocarrier for the drug delivery of acyclovir. ChemistrySelect 5:14564–1457110.1002/slct.202003213 ↗
29. Rahmani F, Jafariazar Z, Mousavi Z, Kazemi NM (2024) Synthesis of Zn2(BDC)2(DABCO) metal–organic framework and its polyethylene glycol composite for acetaminophen delivery. Iran J Sci 48:397–40710.1007/s40995-023-01544-1 ↗
30. Verma P, Bannon MS, Kuenen MK, Raj S, Dhakal A, Stone K, Nichols AW, Machan CW, Colón YJ, Letteri RA, Giri G (2024) Expanding the design space of polymer–metal organic framework (MOF) gels by understanding polymer–MOF interactions. Chem Mater 36:9356–936910.1021/acs.chemmater.4c00112 ↗
31. Wang C, Jia X, Zhen W, Zhang M, Jiang X (2019) Small-sized MOF-constructed multifunctional diagnosis and therapy platform for tumor. ACS Biomater Sci Eng 5:4435–444110.1021/acsbiomaterials.9b00813 ↗
32. Luo Z, Jiang L, Yang S, Li Z, Soh WMW, Zheng L, Loh XJ, Wu YL (2019) Light-induced redox-responsive smart drug delivery system by using selenium-containing polymer@MOF shell/core nanocomposite. Adv Healthc Mater 8:190040610.1002/adhm.201900406 ↗
33. Huang Y, Tang H, Meng X, Liu D, Liu Y, Chen B, Zou Z (2014) γ-Cyclodextrin metal-organic frameworks as the promising carrier for pulmonary delivery of cyclosporine A. Biomed Pharmacother 171:11617410.1016/j.biopha.2024.116174 ↗
34. Cai M, Liang W, Wang K, Yin D, Fu T, Zhu R, Qu C, Dong X, Ni J, Yin X (2022) Aperture modulation of isoreticular metal organic frameworks for targeted antitumor drug delivery. ACS Appl Mater Interfaces 14:36366–3637810.1021/acsami.2c07450 ↗
35. Chen X, Zhuang Y, Rampal N, Hewitt R, Divitini G, O’Keefe CA, Liu X, Whitaker DJ, Wills JW, Jugdaohsingh R, Powell JJ, Yu H, Grey CP, Scherman OA, Fairen-Jimenez D (2021) Formulation of metal–organic framework-based drug carriers by controlled coordination of methoxy PEG phosphate: boosting colloidal stability and redispersibility. J Am Chem Soc 143:13557–1357210.1021/jacs.1c03943 ↗
36. Wagner I, Spiegel S, Brückel J, Schwotzer M, Welle A, Stenzel MH, Bräse S, Begum S, Tsotsalas M (2023) Biofunctionalization of metal–organic framework nanoparticles via combined nitroxide-mediated polymerization and nitroxide exchange reaction. Macromol Mater Eng 308:230004810.1002/mame.202300048 ↗
37. Nguyen Thi HP, Ninh HD, Tran CV, Le BT, Bhosale SV, La DD (2019) Size-control and surface modification of flexible metal-organic framework MIL-53(Fe) by polyethyleneglycol for 5- fluorouracil anticancer drug delivery. ChemistrySelect 4:2333–233810.1002/slct.201803887 ↗